Holen Sie sich die Stockscreener-App
8.40
7.01%
0.55
Handel nachbörslich:
8.16
-0.24
-2.86%
Schlusskurs vom Vortag:
$7.85
Offen:
$7.88
24-Stunden-Volumen:
48,564
Relative Volume:
0.64
Marktkapitalisierung:
$116.38M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-8.89M
KGV:
-12.00
EPS:
-0.7
Netto-Cashflow:
$-6.48M
1W Leistung:
+1.94%
1M Leistung:
-15.92%
6M Leistung:
-14.37%
1J Leistung:
-39.74%
1-Tages-Spanne:
$7.88
$8.53
1-Wochen-Bereich:
$7.78
$8.5619
52-Wochen-Spanne:
$7.78
$15.47
Greenwich Lifesciences Inc Stock (GLSI) Company Profile
Firmenname
Greenwich Lifesciences Inc
Sektor
Branche
Telefon
203-434-3290
Adresse
3992 BLUEBONNET DR, BUILDING 14, STAFFORD
Vergleichen Sie GLSI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GLSI
Greenwich Lifesciences Inc
|
8.40 | 108.76M | 0 | -8.89M | -6.48M | -0.70 |
|
VRTX
Vertex Pharmaceuticals Inc
|
429.82 | 107.58B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
787.32 | 80.03B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.80 | 57.37B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
917.93 | 55.83B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
209.02 | 44.13B | 447.02M | -1.18B | -906.14M | -6.1812 |
Greenwich Lifesciences Inc Stock (GLSI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-20 | Eingeleitet | Noble Capital Markets | Outperform |
| 2021-09-01 | Eingeleitet | H.C. Wainwright | Buy |
Greenwich Lifesciences Inc Aktie (GLSI) Neueste Nachrichten
Is Greenwich LifeSciences Inc. stock safe for conservative investorsRate Cut & Real-Time Volume Analysis - newser.com
Why Greenwich LifeSciences Inc. stock remains on watchlistsEarnings Risk Summary & Risk Controlled Swing Trade Alerts - newser.com
Greenwich LifeSciences Inc. stock daily chart insightsQuarterly Growth Report & Technical Pattern Recognition Alerts - newser.com
What recovery options are there for Greenwich LifeSciences Inc.July 2025 Summary & Expert Approved Momentum Trade Ideas - newser.com
(GLSI) Movement as an Input in Quant Signal Sets - news.stocktradersdaily.com
Can Greenwich LifeSciences Inc. stock surprise with earnings upside2025 EndofYear Setup & Expert Verified Movement Alerts - newser.com
How to interpret RSI for Greenwich LifeSciences Inc. stockMarket Growth Summary & Expert Curated Trade Ideas - newser.com
Key resistance and support levels for Greenwich LifeSciences Inc.Watch List & Community Verified Swing Trade Signals - newser.com
Published on: 2025-11-14 19:58:18 - newser.com
Published on: 2025-11-14 17:28:35 - newser.com
Greenwich LifeSciences, Inc. SEC 10-Q Report - TradingView
Published on: 2025-11-14 13:13:03 - newser.com
When is the best time to exit Greenwich LifeSciences Inc.Trade Exit Summary & AI Based Buy and Sell Signals - newser.com
What candlestick patterns are forming on Greenwich LifeSciences Inc.July 2025 Setups & Verified Swing Trading Watchlists - newser.com
Several Insiders Invested In Greenwich LifeSciences Flagging Positive News - Yahoo Finance
Is Greenwich LifeSciences Inc a good long term investmentLong-Term Growth Stocks & Small Budget Capital Growth - earlytimes.in
Published on: 2025-11-13 03:10:11 - newser.com
Greenwich LifeSciences CEO Makes Bold Stock Purchase! - TipRanks
Greenwich LifeSciences CEO and CFO Snehal Patel Acquires 10,600 Shares - TradingView
[Form 4] Greenwich LifeSciences, Inc. Insider Trading Activity - Stock Titan
Greenwich LifeSciences Inc Stock Analysis and ForecastMarket Sentiment Extremes & Watch Expert Picks Before They Rally - earlytimes.in
Published on: 2025-11-10 09:06:18 - newser.com
Published on: 2025-11-10 00:18:55 - newser.com
Published on: 2025-11-09 13:08:04 - newser.com
Published on: 2025-11-07 02:38:53 - newser.com
Finanzdaten der Greenwich Lifesciences Inc-Aktie (GLSI)
Umsatz
Nettogewinn
Free Cashflow
ENV
Greenwich Lifesciences Inc-Aktie (GLSI) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Patel Snehal | CEO and CFO |
Oct 31 '25 |
Buy |
9.26 |
2,300 |
21,298 |
5,572,902 |
| Patel Snehal | CEO and CFO |
Apr 25 '25 |
Buy |
9.88 |
3,600 |
35,568 |
5,570,602 |
| Patel Snehal | CEO and CFO |
Apr 17 '25 |
Buy |
8.98 |
5,400 |
48,492 |
5,567,002 |
| Patel Snehal | CEO and CFO |
Apr 07 '25 |
Buy |
9.10 |
3,600 |
32,760 |
5,561,602 |
| Patel Snehal | CEO and CFO |
Apr 04 '25 |
Buy |
8.73 |
5,500 |
48,015 |
5,558,002 |
| Patel Snehal | CEO and CFO |
Jan 10 '25 |
Buy |
12.51 |
2,500 |
31,275 |
5,552,502 |
| Patel Snehal | CEO and CFO |
Jan 07 '25 |
Buy |
13.75 |
1,800 |
24,750 |
5,550,002 |
| Patel Snehal | CEO and CFO |
Jan 06 '25 |
Buy |
13.31 |
1,100 |
14,641 |
5,548,202 |
| Patel Snehal | CEO and CFO |
Jan 03 '25 |
Buy |
12.95 |
3,400 |
44,030 |
5,547,102 |
| Patel Snehal | CEO and CFO |
Jan 02 '25 |
Buy |
11.97 |
2,000 |
23,940 |
5,543,702 |
0.53%
1.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):